| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD.V99.10.3806 |
| P698 | PubMed publication ID | 11986240 |
| P50 | author | Andreas Rosenwald | Q28379725 |
| Hans Konrad Müller-Hermelink | Q19284834 | ||
| P2093 | author name string | German Ott | |
| Martin Wilhelm | |||
| Thomas Rüdiger | |||
| Tiemo Katzenberger | |||
| Jörg Kalla | |||
| M Michaela Ott | |||
| Justus G Müller | |||
| Andreas Lohr | |||
| Steffi Kindelberger | |||
| P433 | issue | 10 | |
| P921 | main subject | follicular lymphoma | Q123251 |
| immunohistochemistry | Q899285 | ||
| P304 | page(s) | 3806-3812 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3 | |
| P478 | volume | 99 |
| Q35988134 | ''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases |
| Q35703359 | A case of an abdominal mass: follicular lymphoma |
| Q24653343 | A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score |
| Q81760666 | A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma |
| Q91956211 | A rare case of primary conjunctival Follicular Lymphoma grade 3B |
| Q39950688 | Advanced-stage follicular lymphoma in the rituximab era: when should patients receive anthracycline-based chemotherapy? |
| Q53514319 | Analysis of follicular lymphoma by dual-color fluorescence in situ hybridization. |
| Q81329147 | BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation |
| Q48276956 | Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study |
| Q92645380 | CD38 expression on paraffin sections distinguishes follicular lymphoma from reactive follicular hyperplasia |
| Q49151446 | CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases |
| Q79108467 | Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma |
| Q33386690 | Classification of lymphoid neoplasms: the microscope as a tool for disease discovery |
| Q41874955 | Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas |
| Q38781630 | Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component |
| Q35213318 | Cytogenetic evolution of follicular lymphoma |
| Q34801199 | Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens |
| Q54471878 | Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma. |
| Q37045646 | Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy? |
| Q84475936 | Fluorescence in situ hybridization studies on direct smears: an approach to enhance the fine-needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas |
| Q92185611 | Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs |
| Q38289326 | Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles |
| Q43220044 | Follicular lymphoma grade 3B: is it a real disease? |
| Q26851450 | Follicular lymphoma: 2011 update on diagnosis and management |
| Q22252956 | Follicular lymphoma: 2012 update on diagnosis and management |
| Q37810093 | Follicular lymphoma: the case for timely intervention |
| Q37275890 | Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations |
| Q37808325 | Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy |
| Q37677620 | Gastrointestinal follicular lymphoma: review of the literature |
| Q52806970 | Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2. |
| Q35122234 | Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas: Marginal zone lymphomas |
| Q24203878 | High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults |
| Q42033001 | Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components |
| Q37369563 | Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups |
| Q52689206 | Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort. |
| Q50527084 | Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. |
| Q24240781 | Interferon-alpha for maintenance of follicular lymphoma |
| Q78800404 | Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients |
| Q81623764 | Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances |
| Q38157345 | Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines |
| Q83938141 | Methotrexate-associated lymphoproliferative disorder mimicking composite lymphoma |
| Q60345350 | Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status |
| Q36622615 | Molecular pathways in follicular lymphoma. |
| Q24240865 | Myeloablative high-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults |
| Q36679573 | Nodal Follicular Lymphomas: A Clinicopathological Study from a Tertiary Care Centre in South India |
| Q36763463 | Nodal aggressive B-cell lymphomas: a diagnostic approach |
| Q26829315 | Nodal and leukemic small B-cell neoplasms |
| Q37721816 | Nodal follicular lymphoma: the role of radiotherapy for stages I and II. |
| Q79603667 | Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations |
| Q34481343 | Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas |
| Q53241661 | Predictive value of prognostic indices in patients with follicular lymphomas. |
| Q82717691 | Prognosis of follicular lymphomas |
| Q38836134 | Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium. |
| Q36971217 | Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3 |
| Q53318271 | Prognostic significance of secondary cytogenetic alterations in follicular lymphomas. |
| Q39063872 | Recommendations for Clinical Trial Development in Follicular Lymphoma |
| Q36684897 | Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. |
| Q31041738 | Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray |
| Q58785964 | Spotlight on copanlisib and its potential in the treatment of relapsed/refractory follicular lymphoma: evidence to date |
| Q46741633 | Survival in non-Hodgkin's lymphoma by histology and family history |
| Q35029409 | The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications |
| Q37653274 | The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. |
| Q36970950 | The curability of follicular lymphoma |
| Q38010331 | The current lymphoma classification: new concepts and practical applications triumphs and woes |
| Q46961773 | The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma. |
| Q27693252 | Treatment strategies for nodal and gastrointestinal follicular lymphoma: Current status and future development |
| Q83162393 | Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology |
| Q64086763 | Unraveling Tumor Heterogeneity in an Apparently Monolithic Disease: BCL2 and Other Players in the Genetic Landscape of Nodal Follicular Lymphoma |
| Q37329268 | t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region |
Search more.